Quarterly ResultJul 31, 2026, 05:12 PM
Illumina Q2 Revenue $1.16B, Net Income $207M; SomaLogic Acquisition Update
AI Summary
Illumina reported Q2 2026 revenue of $1.16 billion, an increase from $1.06 billion in Q2 2025. However, net income for the quarter decreased to $207 million from $235 million in the prior year. The company also provided an update on the January 30, 2026 acquisition of SomaLogic for $460 million, which is expected to enhance its proteomics market presence and multiomics strategy, contributing to an increase in goodwill and intangible assets.
Key Highlights
- SomaLogic acquisition completed January 30, 2026, for $460 million.
- Q2 2026 total revenue increased to $1.16 billion from $1.06 billion YoY.
- Q2 2026 net income decreased to $207 million from $235 million YoY.
- Q2 2026 diluted EPS was $1.35, down from $1.49 YoY.
- YTD 2026 total revenue increased to $2.25 billion from $2.10 billion YoY.
- YTD 2026 net income decreased to $340 million from $366 million YoY.
- Cash and cash equivalents were $1.04 billion as of June 28, 2026.
- Goodwill increased to $1.28 billion from $1.11 billion due to acquisition.
Price Impact
More from ILMN